Archive for the ‘Stem Cell Research’ Category

ARVO Weighs In on Stem Cell Ruling

Thursday, September 2nd, 2010

The Association for Research in Vision & Ophthalmology released a statement on Wednesday opposing the ruling by Judge Royce Lamberth, which eventually halted all intramural research with human embryonic stem cells at the National Institutes of Health.

The statement (PDF) reads, in part:

ARVO is troubled by this barrier to research that has the potential to restore sight and mitigate eye damage. ARVO members investigate hESC therapies for treating diseases such as age-related macular degeneration (AMD), diabetic retinopathy, glaucoma and corneal disease, along with studies related to eye tissue transplantation, regeneration and engineering. ARVO’s policy supports technological developments and policies that encourage all facets of stem cell research, including research utilizing hESCs.

ARVO, a Research!America member, becomes the latest in a line of advocacy groups and others that have spoken out in opposition of Lamberth’s ruling.

NYT Interviews Elaine Fuchs

Friday, June 25th, 2010

In a story published on Monday, the New York Times interviewed Elaine Fuchs, PhD. Fuchs, a professor at Rockefeller University and a Howard Hughes Medical Investigator – both are Research!America members – talked about breaking down barriers as a female scientist and what she hopes to learn from studying skin stem cells.

When I was child in 1950s Chicago, there weren’t many women scientists. So to ask the kinds of questions that interested me was unusual. I remember as one of three females among 200 male chemistry majors at the University of Illinois, I was terrified that if I did well in class, the professors would think I’d cheated. That’s how much I didn’t think I belonged. So I studied like crazy and routinely got the best grades on examinations because if I was No. 1, then who could I have cheated from?

Her current research into skin stem cells may lead to better treatments for burn victims, Fuchs said, and possibly even corneal blindness.

And she pushes for more embryonic stem cell research because, she said, it’s important to understand how they function. She added that she is in favor of eventually focusing on adult stem cells, but “we’re not at that point yet.”

PBS Documentary Sheds New Light on Stem Cell Research

Friday, June 11th, 2010

A new addition to the PBS Independent Lens documentary series, “Mapping Stem Cell Research: Terra Incognita,” explores the developing field in of stem cell research through personal stories.

The documentary centers on Jack Kessler, MD, Chairman of the Department of Neurology and Director of the Feinberg Neuroscience Institute at Northwestern University in Evanston, IL; the Institute is a part of the Feinberg School of Medicine, which is a Research!America member. whose Kessler’s daughter broke her spine during a skiing accident and now must use a wheel chair. Kessler discusses how the accident motivated him to pursue research on how to use stem cells to repair broken spinal tissue.

The film also follows the day-to-day routine of Caroline, the daughter of one of Kessler’s colleagues, who sustained a C-5 spinal cord injury in a swimming accident and now has very limited use of her hands and no use of her lower body. Caroline says in the video that when she starts to think about stem cell research and what it could do, it makes it hard for her to be content in her chair.

Kessler and the two graduate students who the documentary follows use a nano-engineered material created by Kessler’s colleague, Dr. Samuel Stupp, PhD, professor of materials science, chemistry and medicine at Northwestern University, to repair lesions in the spinal cord. The material, a gel, acts as like a scaffolding down which axons, or spinal nerves, can grow across an injury site in place of an extracellular matrix, which is damaged during an injury.

By the end of the film, Kessler’s research team is able to get 80% of the axons in the gel-treated test mice to enter the injury site, and 1/3 to go all the way through the lesion. Before they can get their work published, however, they must try different techniques to prove that it works.

“No one treatment is going to solve these very complicated problems,” Kessler said.

One common thread which binds the storylines together is the many obstacles to stem cell research. Kessler says one of the hardest things about his work is the frustration with peoples’ misconceptions of the potential of a zygote for life. Kessler recounts how the concept of the earth being the center of the universe was once considered extremely controversial, and compares this revolution in science to the revolution in medicine he believes stem cells will bring.

“The same thing is true now with a lot of issues about stem cells where there are myths being told about stem cells. People firmly believe things that simply are not true, and we have to change attitudes,” Kessler said.

The film addresses ethical concerns surrounding stem cell research, chiefly through footage of class discussions with bioethicist Laurie Zoloth, PhD, one of Kessler’s colleagues at Northwestern University’s Center for Bioethics, Science and Society. Zoloth’s students question the moral status of an embryo by examining different religions’ views on the point of conception, and Kessler’s class elucidates the difference between conception and fertilization.

“If you could heal a spinal cord injury, how could you not want to?” Zoloth asks. She challenges the listener to define what it means to be human, to be free, and what we should do about the suffering of others.

Kessler’s views are clear.

“What makes me human is not my suffering. What makes me human is my yearning to heal,” Kessler says. “If you see somebody in pain, it’s your job to try and help them … I absolutely reject anyone who would tell me that it’s wrong to try and alleviate suffering.”

No matter the view on whether stem cell research is right or wrong, Kessler says this science is still terra incognita, or new landscape.

“It’s very easy to think things done, and very hard to actually go do in the laboratory,” Kessler says. “Patience is just something that you have no choice you have to have. Whether it is a change in our daily routine or a change in the way we think about the entire world, change is always difficult to deal with, and science does change the world. It forces us to begin to think how we’re going to live our lives in a different way.”

NIH Approves 13 Additional Stem Cell Lines

Wednesday, April 28th, 2010

In today’s Washington Post, Rob Stein writes about the National Institutes of Health announcement that 13 additional lines of human embryonic stem cells are eligible for federal funding.

“Many people who had been working on these lines, and concerned about whether they would be able to continue to work with these lines, will now be reassured that their research can now go forward,” NIH Director Francis S. Collins said Tuesday.

Read about all the eligible lines on the NIH’s Human Embryonic Stem Cell Registry.

Research!America’s website has more information about stem cell research.

Stem Cells To Improve Damaged Hearts

Thursday, April 22nd, 2010

A breakthrough in stem cell use may be just around the corner according to an article in O, The Oprah Magazine. Many doctors believe that over the next decade doctors will be able to restore damaged hearts that were once thought to be irreversibly damaged. Cardiovascular disease affects an estimated 81 million Americans and is the leading cause of death for both men and women so this new idea of using stem cells to repair hearts could make an enormous impact.

One of the biggest discoveries regarding stem cells happened in 2007 when it was discovered that there is a way to transform ordinary human adult skin cells back into stem cells which are known as induced pluripotent stem cells, or IPS stem cells. This process is done by manipulating a small piece of genetic code and then IPS cells can be chemically prodded to become almost any tissue.

According to Deepak Srivastava, MD, director of the Gladstone Institute of Cardiovascular Disease in San Francisco, the most exciting of the new IPS related heart treatments is heart “patches.” These heart patches are newly minted heart cells, yoked together on lab-constructed scaffolding that could be grafted onto a heart to offset damage after a heart attack. Maybe even one day, probably not for 20 years or so, an entire replacement organ could be created.

Compared to what comes along with heart problems now such as rejection of a new heart, waiting for an organ donor, and waiting as drugs are tested on rodents, this is an enormous advancement.

60 Minutes: The Snake Oil Salesman

Monday, April 19th, 2010

Last night’s 60 Minutes’ lead story, 21st Century Snake Oil, focused on bogus stem cell therapies that are being sold to desperate patients. Many patients who have been diagnosed with diseases such as multiple sclerosis, cancer and Lou Gehrig’s disease go to these doctors and made up clinics who promise to use stem cell research to essentially cure their disease. 60 Minutes exposed two men who are scamming people out of thousands of dollars.

This piece also discussed the promise that stem cell research holds for the future, and this online-only video featured researcher Larry Goldstein:

NPR: Reflecting on a Decade of Stem Cell Research

Wednesday, December 30th, 2009

NPR’s Joe Palca looked back on ten years of stem cell research and stem cell research policy on yesterday’s Morning Edition. Highlights include the future of stem cell research techniques and treatments and Proposition 71:

In California, voters authorized spending $3 billion over 10 years for embryonic stem cell research. A bipartisan Congress voted to ease federal restrictions, legislation which Bush vetoed. And opponents continued to push for a total ban on the research.

Robert Klein, JD, a leader in this initiative, will be honored with the Gordon and Llura Gund Leadership Award at Research!America’s Advocacy Awards event on March 16, 2010.

Stem Cell Research Moves Forward in 2009

Thursday, December 24th, 2009

2009 was a major year for stem cell research, with President Obama overturning restrictions on stem cell research and more recently, federally funded scientists beginning research on stem cell lines approved under the National Institutes of Health’s guidelines.

Harvard Magazine looks ahead to the future of stem cell research, from accelerating personalized treatments to new collaborations between disciplines. The article describes how Harvard scientists are using stem cells as research tools in innovative and varied ways.

Research!America continues to be a resource for stem cell research advocates. Linday’s Life Science Communication blog talked about the need for stem cell research funding and pointed her readers to Research!America’s stem cell research issue page.

NIH Approves Use of First Human Embryonic Stem Cell Lines

Wednesday, December 2nd, 2009

Francis Collins, MD, PhD, Director of the National Institutes of Health, just announced that the first human embryonic stem cell lines are eligible for NIH-funded researchers’ use. The stem cell lines were derived under the NIH Guidelines for Human Stem Cell Research adopted in July 2009. From The Washington Post:

“This is a real change in the landscape,” said NIH Director Francis Collins. “This is the first down payment on what is going to be a much longer list . . . that will empower the scientific community to explore the potential of embryonic stem cell research.”

An NIH statement said that grants proposing the use of human embryonic stem cells had been postponed until the lines were approved.

The Houston Chronicle: Baker Institute Blog

Thursday, October 22nd, 2009

The James A. Baker III Institute for Public Policy, a nonpartisan think tank, has launched a new blog which is hosted by The Houston Chronicle. The blog publishes posts on current policy issues, including some related to science and technology policy, like this one on embryonic stem cell research:

Wouldn’t we be better served as a public supporting this research through the NIH where peer-review exists and all grant information is released to the general public? The NIH is recognized worldwide as the leader and model for biomedical research. It requires all research to be reviewed through internal review boards and projects that it funds must be proven to be ethically sound and appropriate. Wouldn’t we want this for embryonic research?

Stem Cell Battles: 2009 World Stem Cell Summit Exceeds All Expectations

Friday, October 16th, 2009

Don Reed, Vice President for Public Policy at Americans for Cures Foundation wrote a detailed post about September’s 2009 World Stem Cell Summit on his blog Stem Cell Battles. Reed participated on a panel, “Stem Cell Action—A New Agenda for Advocates” with Research!America President Mary Woolley.

Mary Wooley, President of Research!America, said much that resonated with the room; you could feel that tingle when speaker and audience connect.

We need to raise the overall awareness of science in America, she said. If you ask a citizen to name a scientist, they will usually think of Einstein, but after that…usually no one. How many movie stars, athletes, politicians can we name? Dozens. But folks whose work saves lives and eases suffering? We need to bring scientists into the public eye, as the fascinating people they are.

Continue reading the post here.

NHLBI Awards $170 Million to Fund Stem Cell Research

Thursday, October 15th, 2009

From NIH News:

The National Heart, Lung, and Blood Institute (NHLBI), one of the National Institutes of Health, has awarded $170 million to be paid over seven years to 18 teams of research scientists to develop the high-potential field of stem and progenitor cell tools and therapies.

Many of the researchers receiving awards come from Research!America member institutions, including University of Pennsylvania, Massachusetts General Hospital, Johns Hopkins University, Vanderbilt University, Stanford University, Fred Hutchinson Cancer Research Center and University of Texas Southwestern Medical Center.

The recent grants are aligned with public support for this type of research. A 2009 Research!America public opinion poll found that 39% of Americans strongly favor expanded funding for embryonic stem cell research.

Show Your Support for Federal Funding of Stem Cell Research

Wednesday, May 6th, 2009

Submit Comments on NIH Draft Guidelines

Your voice is needed. NIH is requesting feedback from the public on new guidelines for federal funding of embryonic stem cell research, and significant opposition is expected.

President Obama’s March 9 Executive Order lifted the Bush Administration’s restrictions on embryonic stem cell research and instructed the NIH to develop guidelines for federal funding. Please submit your comments on the guidelines by May 26 to show your support for federal funding of stem cell research — NIH will be considering both the content and the volume of the comments received.

We have provided sample comment text below that any advocate can submit to NIH. However, we encourage you to modify the comments based on your reasons for supporting stem cell research or expertise you may have in the field. To review the guidelines before you submit your comment, go to: http://stemcells.nih.gov/policy/2009draft.

How to Submit Your Comments – Deadline May 26

  • To access the NIH comment form, go to: http://nihoerextra.nih.gov/stem_cells/add.htm
  • Provide your name, and select ’self’ for Affiliation; and
  • Copy and paste the text below into the comment box, edit as appropriate and submit your comments.

Sample Comment Text
It is important for the federal government to support all types of stem cell research. Our nation’s leadership in health-related research depends upon such funding, as does the health of its citizens. A majority of Americans (73%) favor federal funding for embryonic stem cell research according to a Research!America poll. The final guidelines for federal funding of embryonic stem cell research must ensure that science can progress to the fullest extent possible.

I am pleased that the draft guidelines would expand the number of embryonic stem cell lines that are eligible for federal funding. However, the final guidelines should allow federal funding of all avenues of stem cell research. Specifically, the guidelines must ensure that any line that is currently eligible for funding should remain eligible so that research underway is not halted. It is also important for the guidelines to support funding of research on stem cell lines derived from somatic cell nuclear transfer. The NIH should continue to monitor developments in the field and to update these guidelines as the research progresses.

The Burrill Report: Obama Overturns Bush Restrictions on Stem Cells

Friday, March 13th, 2009

A podcast on The Burrill Report, a life sciences news Web site, features Stacie Propst, vice president of policy and outreach at Research!America. The interview with Propst covers the recent executive order lifting restrictions on stem cell research funding and discusses the role of science in politics.

President Barack Obama’s executive order removing barriers to scientific research involving human embryonic stem cells overturned Bush era restriction that significantly limited federal funding of this work. At the same time, Obama issued a memorandum on scientific integrity – part of an effort, he said, to “restore scientific integrity in government decision making.” We spoke to Stacie Propst, vice president of scientific policy and outreach for the advocacy group Research!America about the Obama executive order, the changes he is bringing to the nation’s science policy, and whether there’s any hope for science to become delinked from politics in the future.

The podcast is at the top of this page.

Research!America in Reuters Story: States and Stem Cell Research

Tuesday, March 10th, 2009

Research!America was quoted in a Reuters story yesterday about the potential benefit to states that funded embryonic stem cell research while federal restrictions were in place. The story suggests these states may be first to benefit from President Obama’s executive order today overturning the restrictions.

State funds helped nourish a stem cell research infrastructure and attracted scientists who may not have had access to funding elsewhere, Stacie Propst of the Research! America advocacy group said.

“The people who were truly interested in that type of research went to those states. They weren’t going to stay somewhere where they could not do the kind of work they wanted to do,” Propst said.

Read the entire article online.

Stem cell research is just one type of research that benefits state economies. See Research!America’s Economic Impact by State tool which shows how research is an economic driver.

Stem Cell Research Restrictions Overturned: Research!America Praises President Obama’s Executive Order

Monday, March 9th, 2009

Call to Congress: Pass the Stem Cell Research Enhancement Act Soon

WASHINGTON—March 9, 2009—Research!America’s Chair, The Honorable John Edward Porter, and President and CEO, Mary Woolley, responded to President Obama’s executive order today overturning the restrictions on embryonic stem cell research:

“Research!America applauds the president’s action to lift restrictions that for eight years have slowed research to explore the potential of embryonic stem cells to halt and even reverse disease and disability,” Porter said. “President Obama’s executive order will allow this field of research to proceed. For progress to continue, Congress must quickly pass the Stem Cell Research Enhancement Act (H.R. 873/S. 487) recently re-introduced in the House by Rep. Diana DeGette (CO) and in the Senate by Sen. Tom Harkin (IA).”

Woolley said, “Twice previously and in a strongly bipartisan fashion, Congress passed identical legislation to broaden federal policy on embryonic stem cell research, but the legislation was vetoed both times by President Bush, most recently in 2007. We urge Congress to act now and make 2009 the year that stem cell research can begin to deliver on the expectations of scientists and the hopes of the public.

Read the rest of the release.

Obama Lifts Restrictions on Embryonic Stem Cell Research

Monday, March 9th, 2009

Show Your Thanks

Today President Obama issued an Executive Order lifting the restrictions on federal funding for embryonic stem cell research that have been in place since August 9, 2001. Please thank President Obama for taking this important step to advance stem cell research in the U.S.

Federal funding will now be allowed for research on existing embryonic stem cell lines as well as those created in the future. However, the funding cannot be used to derive new embryonic stem cell lines, because of a long-standing law. The NIH is now responsible for establishing new stem cell research guidelines within 120 days.

President Obama also signed a presidential memorandum directing the Office of Science and Technology Policy to draft guidelines for the use of scientific information and the appointment of science advisers. This action reinforces his commitment to restoring the integrity of science in government actions.

Today’s Executive Order is thanks to eight years of advocacy in support of stem cell research. Additional action by Congress is expected soon and we look forward to continuing to working with our fellow advocates to ensure that the U.S. is a leader in stem cell research.

Houston Chronicle: Stem Cell Research

Tuesday, February 17th, 2009

An editorial by Kirstin Matthews, PhD, a Science and Technology Policy Fellow at Rice Univerity’s Baker Institute for Public Policy, appeared in this weekend’s Houston Chronicle.

Matthews cites public opinion data on stem cell research from from a Research!America poll showing that a majority of Americans support federal funding for stem cell research. The broader scope of her article is on the need for increased federal oversight to regulate stem cell research.

The government must also outlaw any effort to clone a human being, regardless of the source of funding. Human reproductive cloning has been denounced by scientists and policymakers around the world. Fourteen states and more than 40 countries have already banned the practice. This increased federal involvement reflects public sentiment. Public support for stem cell research has increased over the past seven years, with 56 percent of Americans supporting federal funding according to Research!America. And approximately two-thirds of Americans agree that there should be a uniform federal stem cell policy.

Read Matthews’ op-ed here.

Speak Out for Stem Cell Research

Friday, February 13th, 2009

Urge President Obama to Sign Executive Order

Ask President Obama to sign an Executive Order lifting the restrictions on federal funding for embryonic stem cell research. During the campaign and more recently, President Obama said he would reverse the current policy-which limits federal funding for embryonic stem cell research to those lines that were created before August 9, 2001-but he has not yet taken action.

Please call the White House at 202-456-1111 or send President Obama a message now.

Urge President Obama to lift the restrictions on stem cell research without further delay

Time: Stem Cell Research: The Quest Resumes

Friday, January 30th, 2009

TIME’s new cover story is on stem cells and “resuming the quest” now that a new Administration is in place. Focuses on Douglas Melton of Harvard’s Stem Cell Institute. Writer Alice Park also mentions some of the private and state organizations that have funded stem cell research.

Scientific inspiration can come from anywhere — a person, an event, even an experiment gone awry. But perhaps nothing can drive innovation more powerfully than the passion born of tragedy. Or, in Douglas Melton’s case, near tragedy. The co-director of the Harvard Stem Cell Institute (HSCI) is one of the leading figures in the search for cures for presently incurable diseases, and his breakthrough work is challenging many long-held beliefs about the ways biology and human development work.

But it was a very personal experience that brought Melton to stem cells, one that 17 years later he still finds difficult to discuss.

Read the article online.